These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 1685125
1. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Johnson MP, Conarty PF, Nichols DE. Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125 [Abstract] [Full Text] [Related]
2. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD, Nichols DE, Yim GK. Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126 [Abstract] [Full Text] [Related]
3. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. McKenna DJ, Guan XM, Shulgin AT. Pharmacol Biochem Behav; 1991 Mar 15; 38(3):505-12. PubMed ID: 1829838 [Abstract] [Full Text] [Related]
4. Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine. Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE. Eur J Pharmacol; 1990 Nov 20; 191(1):1-10. PubMed ID: 1982656 [Abstract] [Full Text] [Related]
5. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. Marona-Lewicka D, Nichols DE. Eur J Pharmacol; 1994 Jun 02; 258(1-2):1-13. PubMed ID: 7925587 [Abstract] [Full Text] [Related]
6. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent. Huang X, Marona-Lewicka D, Nichols DE. Eur J Pharmacol; 1992 Dec 08; 229(1):31-8. PubMed ID: 1473561 [Abstract] [Full Text] [Related]
7. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Crespi D, Mennini T, Gobbi M. Br J Pharmacol; 1997 Aug 08; 121(8):1735-43. PubMed ID: 9283711 [Abstract] [Full Text] [Related]
8. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. Johnson CB, Walther D, Baggott MJ, Baker LE, Baumann MH. J Pharmacol Exp Ther; 2024 Sep 18; 391(1):22-29. PubMed ID: 38272669 [Abstract] [Full Text] [Related]
9. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Hekmatpanah CR, Peroutka SJ. Eur J Pharmacol; 1990 Feb 20; 177(1-2):95-8. PubMed ID: 1971219 [Abstract] [Full Text] [Related]
10. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA. Psychopharmacology (Berl); 1991 Feb 20; 104(3):293-301. PubMed ID: 1924637 [Abstract] [Full Text] [Related]
11. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. Nash JF, Brodkin J. J Pharmacol Exp Ther; 1991 Nov 20; 259(2):820-5. PubMed ID: 1682486 [Abstract] [Full Text] [Related]
12. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Berger UV, Gu XF, Azmitia EC. Eur J Pharmacol; 1992 May 14; 215(2-3):153-60. PubMed ID: 1356787 [Abstract] [Full Text] [Related]
13. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity. Oberlender R, Nichols DE. J Pharmacol Exp Ther; 1990 Dec 14; 255(3):1098-106. PubMed ID: 1979813 [Abstract] [Full Text] [Related]
14. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB. Neuropsychopharmacology; 2005 Mar 14; 30(3):550-60. PubMed ID: 15496938 [Abstract] [Full Text] [Related]
15. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Johnson MP, Hoffman AJ, Nichols DE. Eur J Pharmacol; 1986 Dec 16; 132(2-3):269-76. PubMed ID: 2880735 [Abstract] [Full Text] [Related]
16. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM. Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 16; 25(3):621-38. PubMed ID: 11371001 [Abstract] [Full Text] [Related]
17. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. Gazzara RA, Takeda H, Cho AK, Howard SG. Eur J Pharmacol; 1989 Sep 13; 168(2):209-17. PubMed ID: 2575036 [Abstract] [Full Text] [Related]
18. Psychostimulant-like effects of p-fluoroamphetamine in the rat. Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE. Eur J Pharmacol; 1995 Dec 12; 287(2):105-13. PubMed ID: 8749023 [Abstract] [Full Text] [Related]
19. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Schmidt CJ, Levin JA, Lovenberg W. Biochem Pharmacol; 1987 Mar 01; 36(5):747-55. PubMed ID: 2881549 [Abstract] [Full Text] [Related]
20. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. Johnson MP, Huang XM, Nichols DE. Pharmacol Biochem Behav; 1991 Dec 01; 40(4):915-22. PubMed ID: 1726189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]